Geroprotective Potential Of Anti-Diabetic Medications: Bridging Type 2 Diabetes And Accelerated Aging
It turns out that type 2 diabetes and aging share many underlying biological processes, almost as if diabetes speeds up certain aspects of aging within the body. This connection has led scientists to explore whether medications typically used to treat type 2 diabetes could also offer benefits in slowing down the aging process itself. Researchers are looking into several anti-diabetic drugs, such as metformin and a class of drugs called SGLT-2 inhibitors, to see if they can do more than just manage blood sugar. These medications appear to influence key pathways in our cells that are involved in aging, like those that control cell growth and energy use. By affecting these pathways, they might help reduce cellular “wear and tear,” improve how our cells produce energy, and even reduce chronic low-grade inflammation, which is often linked to aging. While early findings are promising and suggest these drugs could potentially help us live healthier for longer, more extensive studies are needed to fully understand their anti-aging effects in people.
Source: link to paper